Cargando…
A Pathway-Based Strategy to Identify Biomarkers for Lung Cancer Diagnosis and Prognosis
Current research has identified several potential biomarkers for lung cancer diagnosis or prognosis. However, most of these biomarkers are derived from a relatively small number of samples using algorithms at the gene level. Hence, gene expression signatures discovered in these studies have little o...
Autores principales: | Sheng, Mengying, Xie, Xueying, Wang, Jun, Gu, Wanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431770/ https://www.ncbi.nlm.nih.gov/pubmed/30923439 http://dx.doi.org/10.1177/1176934319838494 |
Ejemplares similares
-
Pathway-based Biomarkers for Breast Cancer in Proteomics
por: Zhang, Fan, et al.
Publicado: (2015) -
Identifying biomarkers for breast cancer by gene regulatory network rewiring
por: Wang, Yijuan, et al.
Publicado: (2022) -
Identifying module biomarkers from gastric cancer by differential correlation network
por: Liu, Xiaoping, et al.
Publicado: (2016) -
Identification of Predictive Pathways for Non-Hodgkin Lymphoma Prognosis
por: Han, Xuesong, et al.
Publicado: (2010) -
Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations
por: Aramburu, Ander, et al.
Publicado: (2015)